期刊文献+

奎硫平治疗老年器质性精神障碍的对照研究 被引量:4

A Comparative Study of Quetiapine in the Treatment of Elderly Brain Organic Mental Disorders
原文传递
导出
摘要 目的比较奎硫平与奋乃静治疗老年器质性精神障碍的疗效和安全性。方法将96例老年器质性精神障碍患者,随机分为奎硫平组和奋乃静组,分别给予奎硫平和奋乃静治疗,疗程6周,于治疗前和治疗第2、4、6周末进行简明精神病评定量表(BPRS)评定疗效,用副反应量表(TESS)评定不良反应。结果奎硫平与奋乃静的临床疗效相仿,奎硫平不良反应少而轻结论奎硫平对老年器质性精神障碍有较好的疗效和安全性。 Objective To compare the efficacy and safety of quetiapine and perhenazine in the treatment of elderly brain organic mental disorders. Methods 96 patients of elderly brain organic mental disorders were divided into quetiapine group or per phenazine group respectively for 6 weeks. BPRS and TESS were adopted to two groups to evaluate the efficacy and side effects before and after 2, 4 and 6 weeks of the treatment. Results The efficacy Of quetiapine and perphenazine had no significant difference, but quetiapine had fewer side effects. Conclusion Quetiapine is an effective and safe drug in the treatment of aged brain organic mental disorders.
出处 《中国健康心理学杂志》 2007年第12期1106-1107,共2页 China Journal of Health Psychology
关键词 奎硫平 奋乃静 老年 器质性精神障碍 Quetiapine Perhenazine Aged Brain organic mental disorders
  • 相关文献

参考文献3

二级参考文献31

  • 1[1]Goldstein JM. Atypical antipsychotic drugs :beyond acute psychosis, new directions. Emerging Drugs, 1999,4:127
  • 2[2]Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry,1997,54:549
  • 3[3]Borison RL, Arvanitis LA, Miller BG. ICI 204.636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US Seroquel Study Group. J Clin Psychopharmacol, 1996,16:158
  • 4[4]Arvanitis LA,Miller BG and the Seroquel Trial 13 Group.Multiple fixed doses of "Seroquel"(quetiapine) in patients with acute exacerbation of schizophrenia:a comparison with haloperiadaol and placebo.Biol Psychiatry,1997,42:233
  • 5[5]Beasley CM,Sanger T,Satterlee W,et al.Olanzapine versus placebo:results of double-blind,fixed dose olanzapine trail.Psychopharmacology,1996,124:159
  • 6[6]Tran PV,Hamilton SH,Kuntz AJ,et al.Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
  • 7[7]Kasper S,Muller-Spahn F.Review of quetiapine and its clinical applications in schizophrenia.Exp Opin Pharmacother,2000,1:783
  • 8[8]Purdon S,Malla A,Labelle A,et al.Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.J Psychiatr Neurosci,2001,26:137
  • 9[9]Hellwell J,Mckeller M,Raniwalla J."Seroquel":efficacy in aggression,hostility and low mood of schizophrenia [abstract].Presented at the CINP Congress,1998,Glasgow UK
  • 10[10]Tariot PH,Salzman MD,Yeung PP,et al.Long-term use of quetiapine in elderly patients with psychotic disorders.Clin Ther,2000,22:1068

共引文献394

同被引文献26

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部